Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01614483
Other study ID # INSTAPAWP2YC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2012
Est. completion date November 2012

Study information

Verified date November 2022
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of the project is to provide proof-of-principle that biofortification of cassava with vitamin A is a viable strategy to improve vitamin A status of deficient populations.


Description:

Rationale: Vitamin A deficiency is still common in developing countries and has been proven difficult to combat. A promising approach is to replace common crops with varieties that are naturally richer in vitamin A, which is referred to as biofortification. For cassava, yellow β-carotene rich varieties have recently been introduced in Kenya, and these varieties are now ready to be tested for their efficacy to improve vitamin A status in humans. Objective: The primary objective is to measure the effect of daily consumption of provitamin A biofortified cassava (providing 50% of the age-specific RDA) on vitamin A status in children aged 5-13 years with mild to moderate vitamin A deficiency in Kenya. To determine the bioefficacy of provitamin A carotenoids from biofortified cassava relative to that of a daily B-carotene supplement (comparison with positive control group). Secondary objectives are: 1) to measure the effect of the intervention on immune function indicators and morbidity; 2) to determine to what degree the serum retinol response to the intervention depends on serum concentrations of retinol and zinc at baseline; 3) to determine the effect of the intervention on functional indicators such as dark adaptation capacity, gut integrity, hematology indicators and thyroid status; 4) to determine the mediating effect of SNP's in the BCMO1 gene on treatment outcome. Study design & Study population : In this randomized controlled trial, school children aged 5-13 years living in the Kibwezi area, Kenya. Children will be selected from three (or four) primary schools in the area that have been pre-selected based on the prevalence of vitamin A deficiency, location and willingness to participate. Intervention: After screening for eligibility and a 2-week run-in period (n=360) Children will be randomly allocated to three different treatments: 1) 400 g of yellow cassava providing ~50% of the RDA for vitamin A; and a placebo capsule; 2) 400 g of white cassava; and a placebo capsule; 3) 400 g of white cassava and a capsule containing 100 RAE of all-trans β-carotene. Main study parameters/endpoints: The main outcome measure will be differences in serum retinol concentrations between groups. Other outcome measures include other vitamin A status indicators (β-carotene, retinol binding protein, transthyretin), immune function indicators, dark adaptation, iron status indicators, anthropometrics, gut integrity, and thyroid function.


Recruitment information / eligibility

Status Completed
Enrollment 341
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 61 Months to 13 Years
Eligibility Inclusion Criteria: - Low vitamin A status (retinol binding protein (RBP) at the lowest end of the distribution will be included in the study) Exclusion Criteria: - History or signs of infectious or systemic diseases (e.g. tuberculosis, sickle cell anaemia) - Anaemia, malaria or acute inflammation at the day of baseline measurements

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Yellow cassava
Daily provision of 375 g boiled yellow cassava for 18 weeks, 6 days/week Daily provision of placebo capsule for 18 weeks, 6 days/week
White cassava
Daily provision of 375 g boiled white cassava for 18 weeks, 6 days/ week Daily provision of placebo capsule for 18 weeks, 6 days/ week
White cassava
Daily provision of 375 g boiled white cassava for 18 weeks, 6 days/week Daily provision of B-carotene capsule (1400 µg B-carotene)

Locations

Country Name City State
Kenya Kibwezi District Kibwezi Eastern Kenya

Sponsors (3)

Lead Sponsor Collaborator
Wageningen University European Commission, University of Nairobi

Country where clinical trial is conducted

Kenya, 

References & Publications (3)

Talsma EF, Borgonjen-van den Berg KJ, Melse-Boonstra A, Mayer EV, Verhoef H, Demir AY, Ferguson EL, Kok FJ, Brouwer ID. The potential contribution of yellow cassava to dietary nutrient adequacy of primary-school children in Eastern Kenya; the use of linear programming. Public Health Nutr. 2018 Feb;21(2):365-376. doi: 10.1017/S1368980017002506. Epub 2017 Oct 2. — View Citation

Talsma EF, Brouwer ID, Verhoef H, Mbera GN, Mwangi AM, Demir AY, Maziya-Dixon B, Boy E, Zimmermann MB, Melse-Boonstra A. Biofortified yellow cassava and vitamin A status of Kenyan children: a randomized controlled trial. Am J Clin Nutr. 2016 Jan;103(1):258-67. doi: 10.3945/ajcn.114.100164. Epub 2015 Dec 16. — View Citation

Talsma EF, Melse-Boonstra A, de Kok BP, Mbera GN, Mwangi AM, Brouwer ID. Biofortified cassava with pro-vitamin A is sensory and culturally acceptable for consumption by primary school children in Kenya. PLoS One. 2013 Aug 30;8(8):e73433. doi: 10.1371/journal.pone.0073433. eCollection 2013. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in serum retinol concentration Baseline, end of study (4 months)
Secondary Immune function indicators neopterin, IL-2, IL4, IL10, IL13, TNF-a, IFN-?, TGF-ß in serum; IgA in saliva End of study (4 months)
Secondary Bioefficacy Comparison of change in serum retinol between yellow cassava group and positive control (B-carotene supplement group) Baseline, end of study (4 months)
Secondary Functional indicators Gut integrity, dark adaptation, morbidity End of study (4 months)
Secondary Thyroid function Serum Tg, TSH End of study (4 months
Secondary Effect modification Serum zinc, serum retinol, iron status, polymorphisms Baseline
Secondary Anemia Hemoglobin End of study (4 months)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03353662 - Sub Regional Micronutrient Survey in Ethiopia
Completed NCT01061307 - An Efficacy Trial of Iron, Zinc and Vitamin A Fortified Rice in Children in Satun, Thailand Phase 0
Completed NCT00082420 - Retinol Equivalence of Plant Carotenoids in Children N/A
Completed NCT03383744 - Using Stable Isotopes to Assess the Effectiveness of Vitamin A Supplementation in Cameroon N/A
Recruiting NCT04438200 - Liver and Bone Retinol Levels in Guatemalan Adolescents and Adults
Not yet recruiting NCT06450925 - Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. N/A
Completed NCT02996513 - Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method N/A
Completed NCT02027610 - Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants N/A
Completed NCT02043223 - Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit Phase 2/Phase 3
Completed NCT01922713 - Effect of Daily Consumption of Orange Maize on Breast Milk Retinol in Lactating Zambian Women N/A
Completed NCT05882682 - Impact of Food-to-Food Fortified Cereal Products on Diet Quality in Eldoret, Kenya
Completed NCT04632771 - Nutritional Status and Bouillon Use in Northern Ghana
Completed NCT02760095 - Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Active, not recruiting NCT01476358 - Effect of Vitamin A Supplementation on Immune Responses in Human Neonates Phase 2
Completed NCT04137354 - Iron and Vitamin A in School Children N/A
Completed NCT00198718 - Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates Phase 2
Not yet recruiting NCT04127968 - Efficacy and Safety of Vitamin A Treatment for Children With Sepsis N/A
Completed NCT03640104 - Individualized Dietary Intervention in Breastfeeding Women: Body Weight and Vitamin A Stores N/A
Completed NCT02804490 - Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status Phase 3
Completed NCT02702622 - Vitamin A Equivalence of the Provitamin A in Biofortified Bananas N/A

External Links